The outlook revision is based on a number of factors, including Summa’s strengthened liquidity, solid market position and improved profitability.
Fitch also assigned an “A-” rating to Summa’s $344 million of series 2016 bonds.
More articles on healthcare finance:
This week’s 5 must-reads for hospital CFOs
This week’s 5 must-reads for hospital RCM leaders
Medical bills less burdensome for millions of Americans: 5 things to know
